Pangaea Oncology, S.A. (BME:PANG)
Spain · Delayed Price · Currency is EUR 1.500
0.00 (0.00%)
Jul 17, 2026, 4:00 PM CET
Pangaea Oncology Market Cap
Pangaea Oncology has a market cap or net worth of €53.87 million as of July 17, 2026. Its market cap has decreased by -7.76% in one year.
Market Cap
53.87M
Enterprise Value
56.31M
Revenue
16.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.50
ChartMarket Cap Chart
Since December 29, 2016, Pangaea Oncology's market cap has increased from 30.03M to 53.87M, an increase of 79.40%. That is a compound annual growth rate of 6.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 53.87M | -9.36% |
| Dec 31, 2025 | 59.44M | -2.26% |
| Dec 31, 2024 | 60.81M | 12.24% |
| Dec 29, 2023 | 54.18M | 8.35% |
| Dec 30, 2022 | 50.00M | 41.34% |
| Dec 30, 2021 | 35.38M | 30.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.49B |
| Laboratorios Farmaceuticos Rovi | 2.75B |
| Almirall | 2.32B |
| Faes Farma | 1.37B |
| Oryzon Genomics | 237.84M |
| Prim, S.A. | 224.58M |
| Laboratorio Reig Jofre | 213.30M |
| Atrys Health | 183.31M |